ATE345817T1 - Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung - Google Patents

Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung

Info

Publication number
ATE345817T1
ATE345817T1 AT03706620T AT03706620T ATE345817T1 AT E345817 T1 ATE345817 T1 AT E345817T1 AT 03706620 T AT03706620 T AT 03706620T AT 03706620 T AT03706620 T AT 03706620T AT E345817 T1 ATE345817 T1 AT E345817T1
Authority
AT
Austria
Prior art keywords
oral administration
water soluble
solid solution
poorly water
soluble substance
Prior art date
Application number
AT03706620T
Other languages
English (en)
Inventor
Henricus R M Gorissen
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of ATE345817T1 publication Critical patent/ATE345817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03706620T 2002-02-14 2003-02-11 Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung ATE345817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075623 2002-02-14

Publications (1)

Publication Number Publication Date
ATE345817T1 true ATE345817T1 (de) 2006-12-15

Family

ID=27619166

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706620T ATE345817T1 (de) 2002-02-14 2003-02-11 Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung

Country Status (24)

Country Link
US (2) US20050008697A1 (de)
EP (1) EP1476196B1 (de)
JP (1) JP2005517041A (de)
KR (1) KR101014545B1 (de)
CN (1) CN1273194C (de)
AR (1) AR038681A1 (de)
AT (1) ATE345817T1 (de)
AU (1) AU2003208713B2 (de)
BR (1) BR0307278A (de)
CA (1) CA2472744A1 (de)
DE (1) DE60309839T2 (de)
DK (1) DK1476196T3 (de)
ES (1) ES2277635T3 (de)
HR (1) HRP20040613A2 (de)
IL (2) IL162883A0 (de)
MX (1) MXPA04007852A (de)
NO (1) NO20043832L (de)
PL (1) PL370452A1 (de)
PT (1) PT1476196E (de)
RU (1) RU2314811C2 (de)
SI (1) SI1476196T1 (de)
UA (1) UA79267C2 (de)
WO (1) WO2003068266A1 (de)
ZA (1) ZA200405608B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP2007308479A (ja) 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 固体分散体製剤
AU2007259252A1 (en) * 2006-06-16 2007-12-21 Solvay Pharmaceuticals B.V. Oral pharmaceutical composition of a poorly water-soluble active substance
KR20090033246A (ko) * 2006-06-22 2009-04-01 솔베이 파마슈티칼스 비. 브이 수용성이 불량한 활성 물질의 경구용 약제학적 조성물
CA2656903A1 (en) * 2006-07-06 2008-01-10 Ares Trading S.A. An oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof
JP2010501642A (ja) * 2006-09-01 2010-01-21 テバ ファーマシューティカル インダストリーズ リミティド カルシウム受容体−活性化合物の固体複合材料
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
KR20130097173A (ko) 2010-08-04 2013-09-02 그뤼넨탈 게엠베하 신경병증성 통증을 치료하기 위한 ６’­플루오로­（Ｎ­메틸­ 또는 Ｎ，Ｎ­디메틸­）­４­페닐­４’，９’­디하이드로­３’Ｈ­스피로[사이클로헥산­１，１’­피라노[３，４，ｂ]인돌]­４­아민을 포함하는 약제학적 투여형
WO2012016699A2 (en) * 2010-08-04 2012-02-09 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine
WO2017004733A1 (zh) * 2015-07-03 2017-01-12 浙江海正药业股份有限公司 一种人参皂苷c-k口服固体制剂及其制备方法
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
PL424453A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
WO2020112961A1 (en) * 2018-11-30 2020-06-04 Chemocentryx, Inc. Capsule formulations
WO2025018777A1 (ko) * 2023-07-18 2025-01-23 삼아제약 주식회사 프란루카스트 함유 약제학적 조성물의 제조방법 및 상기 제조방법에 의해 제조된 약제학적 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359167A (en) * 1965-07-22 1967-12-19 Pfizer & Co C Vitamin a compositions
CU35543A1 (es) * 1980-10-09 1983-05-05 Hoffmann La Roche Prostaglandines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
SK285019B6 (sk) * 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions

Also Published As

Publication number Publication date
DE60309839T2 (de) 2007-03-15
UA79267C2 (en) 2007-06-11
CN1273194C (zh) 2006-09-06
JP2005517041A (ja) 2005-06-09
IL162883A (en) 2009-05-04
MXPA04007852A (es) 2004-10-15
CN1633307A (zh) 2005-06-29
ZA200405608B (en) 2005-06-24
IL162883A0 (en) 2005-11-20
ES2277635T3 (es) 2007-07-16
SI1476196T1 (sl) 2007-04-30
EP1476196A1 (de) 2004-11-17
US20050008697A1 (en) 2005-01-13
NO20043832L (no) 2004-09-13
DE60309839D1 (de) 2007-01-04
AR038681A1 (es) 2005-01-26
US20110086844A1 (en) 2011-04-14
DK1476196T3 (da) 2007-03-05
EP1476196B1 (de) 2006-11-22
KR20040085193A (ko) 2004-10-07
RU2004127457A (ru) 2005-04-20
BR0307278A (pt) 2004-12-28
AU2003208713A1 (en) 2003-09-04
WO2003068266A1 (en) 2003-08-21
AU2003208713B2 (en) 2007-10-18
CA2472744A1 (en) 2003-08-21
RU2314811C2 (ru) 2008-01-20
KR101014545B1 (ko) 2011-02-16
AU2003208713B9 (en) 2003-09-04
PT1476196E (pt) 2007-02-28
HRP20040613A2 (en) 2005-04-30
PL370452A1 (en) 2005-05-30
HK1077218A1 (en) 2006-02-10

Similar Documents

Publication Publication Date Title
ATE345817T1 (de) Feste lösung einer schwerwasserlöslichen substanz zur oralen verabreichung
DE69909135D1 (de) Orale zubereitung zur bekämpfung von mundgeruch
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
ATE296619T1 (de) Feste orale dosierungsform von simethicon
ATE380544T1 (de) Umhüllte feste darreichungsform
DE60220661D1 (de) Transdermales pflaster zur verabreichung von fentanyl
DE60224111D1 (de) Bausatz zur Herstellung einer Verabreichungsform zur Abgabe einer bioaktiven Substanz
DK1438040T4 (da) Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt
CY2018005I1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DE50212273D1 (de) Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
DE60016572D1 (de) Wasserbeständiges vorgefertigtes gipsbauelement
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
ATE367831T1 (de) Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung
IS7481A (is) Epóthílon til gjafar um munn
DK1410793T3 (da) Administreringsform af ibuprofen-natrium
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DK1216226T3 (da) Fremgangsmåde til fremstilling af phenyleddikesyrederivater
ID30397A (id) Larutan oral prukaloprida
FI20020593A0 (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
ITTO20030669A1 (it) Procedimento per la preparazione di una dispersione acquosa
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
EE200100381A (et) Morfolinobensamiidi uued soolad
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
DE602004016751D1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1476196

Country of ref document: EP